ifedipine ointment with Lidocaine vs. Diltiazem ointment with Lidocaine for treatment of Anal Fissure
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: K928- Other specified diseases of the digestive system
- Registration Number
- CTRI/2022/04/042081
- Lead Sponsor
- AIIMS Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
with a definitive diagnosis of anal fissure
Exclusion Criteria
1. History of reaction to topical agents.
2. Recurrent anal fissures
3. Associated condition or disease such as severe anaemia, cancer, fistula, abscess, Crohnâ??s disease, HIV related anal ulcer, tuberculosis ulcer, leukemic ulcer, pregnancy, third and fourth degree haemorrhoids, and Diabetes mellitus
4. History of surgical treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of Nifedipine and Diltiazem in anal fissure treatment?
How does the combination of Nifedipine with Lidocaine compare to Diltiazem with Lidocaine in improving anal fissure-related quality of life?
Are there specific biomarkers that predict response to calcium channel blockers like Nifedipine or Diltiazem in anal fissure patients?
What are the known adverse events associated with Nifedipine and Diltiazem topical formulations for anal fissures?
What alternative or competitor drugs exist for treating anal fissures compared to CTRI/2022/04/042081's intervention?